Nirsevimab also achieves good results in everyday clinical practice...

Nirsevimab also achieves good results in everyday clinical practice…

0 Comments

medicine

Thursday, July 11, 2024

Paris RSV prophylaxis with nirsevimab, which is free for all infants in France, significantly reduced the number of hospitalizations for RSV-associated bronchiolitis during the first major seasonal epidemic. This is shown by the results of a case-control study in the New England Journal of Medicine (NEJM 2024; DOI: 10.1056/NEJMoa2314885). The antibody nirsevimab, which blocks the respiratory syncytial virus (RSV)…

#Nirsevimab #achieves #good #results #everyday #clinical #practice..

Leave a Reply

Related Posts